Compared to the control and RSL3@LIPO groups, RSL3@LIPO@GEL dramatically suppressed GPX4 synthesis (Figure 7a,b) and greatly increased the tumor cell lipid‐ROS levels (Figure 7c). The gene discussed is GPX4; the disease is neoplasm.